Pharma and Biotech
| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1027.9% | n/a |
| ROCE | 4172.7% |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 11.1 | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | -84.0% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-21 | 0.32 | (5.90) | (3.05)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-22 | 0.62 | (5.57) | (2.65)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-23 | 0.08 | (4.26) | (1.75)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-24 | 1.91 | (3.01) | (0.87)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-25 | 0.31 | (3.29) | (0.65)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Change of Auditor | 25-Nov-2025 | 07:00 | RNS |
| Total Voting Rights | 31-Oct-2025 | 17:00 | RNS |
| Chill Agrees Settlement with Former Advisers | 23-Oct-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 0.65p |
| Change Today | -0.075p |
| % Change | -10.34 % |
| 52 Week High | 2.15 |
| 52 Week Low | 0.60 |
| Volume | 2,229,430 |
| Shares Issued | 522.93m |
| Market Cap | £3.40m |
| Beta | 0.17 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:14 | 100,000 @ 0.70p |
| 15:05 | 296,430 @ 0.67p |
| 15:00 | 213,208 @ 0.64p |
| 13:40 | 511,507 @ 0.68p |
| 12:27 | 4,000 @ 0.70p |
You are here: research